ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CTLT Catalent Inc

55.07
-0.14 (-0.25%)
After Hours
Last Updated: 16:00:39
Delayed by 15 minutes

Period:

Draw Mode:

Volume 986,393
Bid Price
Ask Price
News -
Day High 55.30

Low
31.8001

52 Week Range

High
60.20

Day Low 55.03
Company Name Stock Ticker Symbol Market Type
Catalent Inc CTLT NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.14 -0.25% 55.07 16:00:39
Open Price Low Price High Price Close Price Prev Close
55.22 55.03 55.30 55.07 55.21
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
12,760 986,393 $ 55.14 $ 54,389,099 - 31.8001 - 60.20
Last Trade Time Type Quantity Stock Price Currency
16:36:06 formt 250 $ 55.07 USD

Catalent (CTLT) Options Flow Summary

Overall Flow

Bullish

Net Premium

50k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

Catalent Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
9.95B 180.74M - 4.26B -256M -1.42 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Catalent News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CTLT Message Board. Create One! See More Posts on CTLT Message Board See More Message Board Posts

Historical CTLT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week56.1956.2555.0355.601,148,776-1.12-1.99%
1 Month54.9656.5453.5154.881,617,4630.110.20%
3 Months56.5057.199953.5155.741,610,803-1.43-2.53%
6 Months41.5060.2041.1555.092,187,68013.5732.70%
1 Year43.2960.2031.800148.652,339,62611.7827.21%
3 Years109.85142.6431.4562.692,076,236-54.78-49.87%
5 Years50.82142.6431.0467.051,686,1174.258.36%

Catalent Description

Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.

Your Recent History

Delayed Upgrade Clock